| 引用本文: | 卢羽玲, 张进燕, 蒋紫云, 廖广凤, 徐秀虹, 肖昔文, 卢汝梅.宽叶匙羹藤中一个新的色原酮及其降血糖活性研究[J].广西植物,2026,46(8):1419-1431.[点击复制] |
| LU Yuling, ZHANG Jinyan, JIANG Ziyun, LIAO Guangfeng,
XU Xiuhong, XIAO Xiwen, LU Rumei.A new chromanone component from Gymnema latifolium and its hypoglycemic activity[J].Guihaia,2026,46(8):1419-1431.[点击复制] |
|
|
【XML】
【Btbtex】
【RIS】
【RefWorks】
【EndNote】
【TXT】
|
| |
|
|
| 本文已被：浏览 72次 下载 7次 |
码上扫一扫！ |
|
|
| 宽叶匙羹藤中一个新的色原酮及其降血糖活性研究 |
|
卢羽玲1, 张进燕1,2, 蒋紫云1, 廖广凤1,2, 徐秀虹1, 肖昔文1, 卢汝梅1,2*
|
|
1. 广西中医药大学 药学院, 南宁 530200;2. 特色中药民族药广西高校工程研究中心, 南宁 530200
|
|
| 摘要: |
| 宽叶匙羹藤在傈僳族的药名为“片鲁爪”,民间常用于糖尿病的治疗。为探究宽叶匙羹藤(Gymnema latifolium)的化学成分及其降血糖活性,该研究综合运用大孔树脂、硅胶、MCI、Sephadex LH-20柱色谱和半制备高效液相色谱等多种分离方法对宽叶匙羹藤乙酸乙酯部位的化学成分进行分离纯化,结合质谱(MS)、核磁共振(NMR)谱及电子圆二色(ECD)谱等方法确定化合物的结构,采用基于HepG2细胞对葡萄糖摄取的方法评价分离所得化合物的体外降血糖活性。结果表明:(1)从乙酸乙酯部位中分离得到15个化合物,分别为calomembranone L(1)、calopolyanic acid(2)、blancoic acid(3)、apetalic acid(4)、isoapetalic acid(5)、apetalic acid methyl ester(6)、isoapetalic acid methyl ester(7)、calopolyanolide B(8)、2-羟基呫吨酮(9)、异胡椒酮 B(10)、lacexanthone(11)、caledonixanthone Q(12)、(7,8-cis-8,8'-trans)-2',4'-二羟基-3,5-二甲氧基-落叶松脂素(13)、(7R,8S)-去氢双松柏醇(14)、(+)-松脂醇(15)。其中,化合物1为新的色原酮类化合物,其余化合物均为首次从匙羹藤属植物中分离得到。(2)降血糖活性实验结果表明,在无显著细胞毒性的浓度下,化合物1、2、3、8、13的HepG2细胞对葡萄糖摄取量分别是对照组的1.47倍、1.47倍、1.12倍、1.49倍和1.23倍,且细胞活力维持在90%以上,这说明以上化合物具有促进HepG2细胞对葡萄糖的摄取作用。该研究结果丰富了宽叶匙羹藤的化学成分库,初步阐明了其降血糖的药效物质基础,为其进一步开发与应用提供了理论依据。 |
| 关键词: 宽叶匙羹藤, 化学成分, 色原酮, calomembranone L, 降血糖活性 |
| DOI：10.11931/guihaia.gxzw202602004 |
| 分类号:Q946 |
| 文章编号:1000-3142(2026)08-1419-13 |
| 基金项目:国家自然科学基金项目(82360823); 广西自然科学基金项目(2025GXNSFBA069359); 2025年自治区级大学生创新训练计划立项项目(S202510600072)。 |
|
| A new chromanone component from Gymnema latifolium and its hypoglycemic activity |
|
LU Yuling1, ZHANG Jinyan1,2, JIANG Ziyun1, LIAO Guangfeng1,2,
XU Xiuhong1, XIAO Xiwen1, LU Rumei1,2*
|
|
1. College of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530200, China;2. University Engineering
Research Center of Characteristic Traditional Chinese Medicine and Ethnomedicine, Nanning 530200, China
|
| Abstract: |
| Gymnema latifolium, referred to as “Pian Lu Zhao” in the Lisu ethnic group, is traditionally employed to treat diabetes mellitus. To explore the chemical constituents and hypoglycemic activity of G. latifolium, this study employed a combination of macroporous resins, silica gel, MCI, Sephadex LH-20 column chromatography, and semi-preparative high-performance liquid chromatography to isolate and purify the chemical constituents from the ethyl acetate fraction of G. latifolium. The structures of the compounds were determined by mass spectrum(MS), nuclear magnetic resonance(NMR)spectroscopy, and electronic circular dischroism(ECD)spectroscopy. The in vitro hypoglycemic activities of the isolated compounds were assessed using glucose uptake assay based on HepG2 cells. The results were as follows:(1)Fifteen compounds were isolated and identified as calomembranone L(1), calopolyanic acid(2), blancoic acid(3), apetalic acid(4), isoapetalic acid(5), apetalic acid methyl ester(6), isoapetalic acid methyl ester(7), calopolyanolide B(8), 2-hydroxy-xanthone(9), isocudraniaxanthone B(10), lacexanthone(11), caledonixanthone Q(12),(7,8-cis-8,8'-trans)-2',4'-dihydroxy-3,5-dimethoxy-lariciresinol(13),(7R,8S)-dehydrodiconiferyl alcohol(14),(+)-pinoresinol(15). Among them, Compound 1 was a new chromanone compound, and compounds 2-15 were isolated from Gymnema plants for the first time.(2)Hypoglycemic activity assays showed that compounds 1, 2, 3, 8 and 13 increased glucose uptake to 1.47, 1.47, 1.12, 1.49 and 1.23 times that of the control group in HepG2 cells, respectively, while exhibiting minimal cytotoxic effects, maintaining cell viability above 90%. This indicated that the above compounds had effects of promoting glucose uptake by HepG2 cells. This study enriches the chemical profile of G. latifolium and preliminarily clarifies the material basis for its hypoglycemic effect, providing a theoretical foundation for its further development and application. |
| Key words: Gymnema latifolium, chemical constituents, chromanone, calomembranone L, hypoglycemic activity |
|
|
|
|
|
